Skip to content Skip to site navigation Skip to local navigation
Department of Health

Medical Services Advisory Committee

  • MSAC
  • About MSAC
    • About MSAC
    • MSAC Process Framework
    • MSAC Executive Terms of Reference
    • MSAC Terms of Reference
    • MSAC Membership
    • ESC Terms of Reference
    • ESC Membership
    • PASC Terms of Reference
    • PASC Membership
    • Frequently Asked Questions
  • MSAC Meetings
    • Meetings
  • Public Funding
    • How to Apply for Public Funding
  • Forms Templates & Guidelines
    • Assessment Groups
    • Applicants
  • Guidelines Review
    • Guidelines Review
    • Guidelines Review Webinars
  • MSAC Applications
    • Application Page
  • Utilisation Monitoring Process
  • You are here:
  • Medical Services Advisory Committee /
  • MSAC Meetings /
  • Meetings /

MSAC - Meeting 30 - 31 March 2016

Page last updated: 01 August 2016

Medical Services Advisory Committee - Applications Considered

Submission Based Assessments

  • Application 1344.1: Podiatric Surgeons for access to a range of MBS numbers for surgery of the foot and ankle
  • Application 1361.2: Transcatheter Aortic Valve Implantation via Transfemoral Delivery
  • Application 1365.1: Active middle ear implants for sensorineural hearing loss

Contracted Assessments

  • Application 1385: Shared Medical Appointments (SMAs) for Type 2 Diabetes Management
  • Application 1366: Transient Elastography at 50Hz for the diagnosis of Liver Fibrosis in patients with confirmed Hepatitis B or confirmed Hepatitis C

Co-dependent applications

  • Application 1172.1: BRAF mutation test for treatment of metastatic melanoma for access to vemurafenib
  • Application 1370: Ocriplasmin for symptomatic vitreomacular adhesion (VMA) including macular hole
  • Application 1377: Optical Coherence Tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
  • Application 1380: BRCA mutation testing to determine eligibility for olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

Other

  • Application 1411.1: Genetic testing for hereditary mutations predisposing to breast and/or ovarian cancer
Listen
  • MSAC Meetings
  • Meetings
    • MSAC – ESC Calendar Key Dates
    • PASC Calendar Key Dates
    • Co-dependent Technologies
  • MSAC Email Bulletin


  • Feedback
Provide feedback

Comments will be used to improve web content and will not be responded to.

Real person check

This form uses a CAPTCHA to ensure that it is submitted by a person, instead of a machine or automated software.


Privacy statement

Your feedback has been submitted

Thank you for taking the time to provide feedback. It will be used to make improvements to this website.

Medical Services Advisory Committee

Medical Services Advisory Committee

© Commonwealth of Australia
ABN: 83 605 426 759

MBS Information

  • MBS Online
  • Legislation that covers the MBS
  • About MBS Factsheets
  • MBS Review

HTA Information

  • What is HTA
  • Australian Government HTA processes

Useful Links

  • MBS Online
  • PBS
  • PBAC
  • PLAC
  • Health Technology Reference Group
  • Healthier Medicare
  • MBS Review
  • TGA
  • HTA Conflict of Interest Guide

About

  • Copyright
  • Linking to this site
  • Accessibility
  • Disclaimer
  • Privacy
  • What is RSS?
  • Contact Us